Carisma Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CARM and buy or sell other stocks, ETFs, and their options commission-free!About CARM
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors.
CEOCraig R. Jalbert
CEOCraig R. Jalbert
Employees46
Employees46
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2016
Founded2016
Employees46
Employees46
CARM Key Statistics
Market cap8.37K
Market cap8.37K
Price-Earnings ratio0.00
Price-Earnings ratio0.00
Dividend yield—
Dividend yield—
Average volume8.55K
Average volume8.55K
High today$0.0002
High today$0.0002
Low today$0.0002
Low today$0.0002
Open price$0.0002
Open price$0.0002
Volume24.00K
Volume24.00K
52 Week high$0.10
52 Week high$0.10
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
Carisma Therapeutics(CARM) stock is priced at $0.00, giving the company a market capitalization of 8.37K. It carries a P/E multiple of 0.00.
As of 2026-10-24, Carisma Therapeutics(CARM) stock has fluctuated between $0.00 and $0.00. The current price stands at $0.00, placing the stock 0.0% above today's low and 0.0% off the high.
The Carisma Therapeutics(CARM)'s current trading volume is 24K, compared to an average daily volume of 8.55K.
In the last year, Carisma Therapeutics(CARM) shares hit a 52-week high of $0.10 and a 52-week low of $0.00.
In the last year, Carisma Therapeutics(CARM) shares hit a 52-week high of $0.10 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own CARM. This list is generated using Robinhood data, and it’s not a recommendation.